Clinical trials
Completed Phase 1 Fibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 4 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 3 |
| RXi Pharmaceuticals, Corp. | 2 |
| Virginia Commonwealth University | 2 |
| ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 1 |
| Blade Therapeutics | 1 |
| Genzyme, a Sanofi Company | 1 |
| Gilead Sciences | 1 |
| GlaxoSmithKline | 1 |
| Hunter Holmes Mcguire Veteran Affairs Medical Center | 1 |
| Jared Jagdeo, MD, MS | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fibrosis | 40 |
| Cicatrix | 4 |
| Carcinoma, Hepatocellular | 3 |
| Hepatic Encephalopathy | 3 |
| Hepatitis C | 3 |
| Idiopathic Pulmonary Fibrosis | 3 |
| Liver Cirrhosis | 3 |
| Lung Diseases | 3 |
| Non-alcoholic Fatty Liver Disease | 3 |
| Cholangitis, Sclerosing | 2 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.